VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Value Add PulseIPO~$1.9B valuation

IQM, Europe's First Public Quantum Company, Admits the Future of the Tech Is Uncertain

IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq July 2 via a SPAC merger with RAAQ at a roughly $1.9 billion valuation, but shares traded below the IPO price for most of the day -- a lukewarm debut IQM's own prospectus arguably invited by warning that 'large-scale commercial traction of quantum computing technology may never occur.' The listing generated approximately $226 million in new liquidity on top of $300 million IQM had already raised last September, and makes IQM the first European quantum company to list in the US, narrowly beating French competitor Pasqal, which has also announced SPAC plans.

~$1.9B
IPO Valuation
SPAC merger (with RAAQ), Nasdaq
Listing Type
~€198M (~$226M) after costs
New Liquidity Generated
$300M
Prior Raise (Sept 2025)
8 -> 22
Customers (2024 -> 2025)
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 2, 2026
3 min read
ShareXLinkedInEmail
KEY TAKEAWAYS FOR VCs & FOUNDERS
1

A quantum computing company's own prospectus admitting large-scale commercial traction 'may never occur' is an unusually candid risk disclosure for a sector otherwise driven by aggressive long-term narratives

2

Growing from 8 customers in 2024 to 22 in 2025, including recent private-sector wins, shows real commercial traction even before quantum computers definitively outperform classical alternatives at scale

3

Trump administration executive orders accelerating US quantum timelines, plus a DOE commitment to a fault-tolerant machine by 2028, give IQM's new Maryland quantum center and Oak Ridge deployment direct policy tailwinds

4

IQM debuting narrowly ahead of French rival Pasqal's own announced SPAC plans makes IQM the first-mover in a two-company European quantum-IPO race playing out in real time

TC
The VC Read · Trace's TakeTrace Cohen

A quantum computing company telling public investors in its own prospectus that commercial traction 'may never occur,' and then watching the stock trade below its IPO price on debut day, is honestly a healthier market reaction than a hype-driven pop would have been -- investors read the risk disclosure and priced it accordingly, which is exactly how this is supposed to work. Growing from 8 to 22 customers in a year, including real private-sector wins, is genuine evidence IQM has a business today even without quantum advantage ever materializing at scale, and that's the more important number than the IPO-day stock move. For founders in deep tech with genuinely uncertain, decade-plus commercialization timelines, IQM's candor is worth studying: public markets seem to reward honest uncertainty over-hyped promises once the initial skepticism is priced in, especially if you can show real customer growth alongside it. Watch the Pasqal SPAC closely as the direct competitive benchmark -- whichever quantum company's stock holds up better after both have fully priced in will tell you a lot about which one public investors actually believe in.

📈 Tech IPO Tracker →

IQM, the Finland-based full-stack quantum computing company, went public on Nasdaq on July 2, 2026 via a SPAC merger with blank-check company RAAQ, at a valuation of roughly $1.9 billion. Shares did not pop -- they spent most of the trading day below the IPO price, a lukewarm welcome that TechCrunch reporting suggests was arguably fueled by IQM's own prospectus, which stated plainly that "large-scale commercial traction of quantum computing technology may never occur."

That warning applies, in fairness, to every company in the quantum computing sector, and it hasn't stopped IQM or its peers from acquiring real, paying customers using the technology as it exists today for tasks like simulations and optimizations. IQM sells both physical quantum computers and cloud-access computing time, with customers including VTT Technical Research Centre of Finland and Germany's Leibniz Supercomputing Centre. "We sell computers into advanced supercomputing centers and data centers, and we sell computing time through the cloud," CEO and co-founder Jan Goetz told TechCrunch. The company grew from 8 customers in 2024 to 22 in 2025, including its first private-sector wins -- real momentum, even as genuine "quantum advantage" (the point at which quantum chips definitively outperform classical computers across a broad range of complex tasks) remains undefined and, per IQM's own filing, possibly permanent uncertainty rather than a matter of when.

The listing's timing benefits from real policy tailwinds: President Trump's recent executive orders aimed at accelerating the US quantum computing timeline have prompted the Department of Energy to commit to deploying "the world's first fault-tolerant, scientifically relevant quantum computer" by 2028. IQM stands to benefit directly, having recently established a quantum tech center in Maryland and deployed a computer at Oak Ridge National Laboratory, part of the DOE -- "we can benefit directly from it," Goetz said, referring to the administration's push, which follows similar national quantum-acceleration announcements from France, Germany and the UK.

“"We sell computers into advanced supercomputing centers and data centers, and we sell computing time through the cloud," CEO and co-founder Jan Goetz told TechCrunch.”

IQM's structure reflects genuine European origins even as it pursues a US listing: founded in 2018 as a spinout from Finland's Aalto University, the company still has two-thirds of its roughly 420-person staff working out of Espoo, with about 100 more based in Munich. Rather than shifting its center of gravity across the Atlantic like many European tech unicorns pursuing US listings, IQM is simultaneously debuting on Nasdaq Helsinki in parallel with its US Nasdaq ticker (IQMX), maintaining continued support from Tesi, Finland's sovereign wealth fund. The RAAQ board, in IQM's prospectus, specifically cited "over €200 million in public support for IQM" from European sovereign states and companies as evidence the company had already demonstrated its ability to operate credibly both within and outside Europe.

Goetz expressed pride at IQM becoming the first European quantum company to list in the US, doing so within a hair's breadth of French competitor Pasqal, which has separately announced its own plans to go public via SPAC. "It always feels good to be first and to be a pioneer, but ultimately it's about long-term success," Goetz said -- a notably measured framing given how close the race with Pasqal actually was. The listing itself generated approximately €198 million ($226 million) in new liquidity after costs, on top of the $300 million IQM had already raised in a private round the previous September. "It's a big success raising very shortly after the Series B," Goetz said, framing the public listing's main goal as positioning IQM more prominently in a technology race that remains, by the company's own admission, full of fundamental unknowns.

For founders and investors in quantum computing and other deep-tech categories with long, uncertain commercialization timelines, IQM's candid prospectus language and lukewarm debut are a useful reminder that public markets can be unforgiving toward a sector's own honest risk disclosures, even when a company shows real customer growth. For LPs, IQM's first-mover advantage over Pasqal in the US listing race, combined with genuine sovereign-fund support from Finland and Trump-administration quantum policy tailwinds, positions it as a credible bellwether for how public markets price quantum computing exposure more broadly.

What to watch: whether IQM's stock recovers above its IPO price once initial market skepticism settles, how Pasqal's competing SPAC listing performs by comparison once it completes, and whether the DOE's 2028 fault-tolerant quantum computer target and broader Trump administration policy support translate into concrete new contracts for IQM's Maryland center and Oak Ridge deployment.

ShareXLinkedInEmail

Originally reported by TechCrunch. Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

Read Next

IPOS-1 filed

Jersey Mike's IPO Filing Shows Just How Far AI Buzzwords Have Spread

Jersey Mike's Subs Inc. filed its S-1 for an IPO on July 2, mentioning 'artificial intelligence' or 'AI' 22 times despite being a sandwich-chain franchisor with no AI product offerings, TechCrunch reported the same day. The filing includes AI in its risk-factor disclosures with only vague language ('We are beginning to use AI Technologies in our business'), while the word 'weather' -- despite an actual 2021 lightning strike damaging a Jersey Mike's location in Texas -- appears just 5 times.

IPOS-1 filed

Scribe Therapeutics, Co-Founded by Nobel Laureate Jennifer Doudna, Files S-1 for Nasdaq IPO

Scribe Therapeutics filed its S-1 with the SEC on July 2, seeking to list on the Nasdaq Global Market under the ticker 'SCTX.' The clinical-stage biotech, co-founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna, has raised roughly $150 million in equity financing since 2017 and is advancing STX-1150 -- an epigenetic-silencing CRISPR candidate for cardiovascular disease -- through an Australian first-in-human trial, while disclosing only $49.7 million in cash and marketable securities against a $175.1 million accumulated deficit.

IPOUp to $25M equity line

Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1

Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.

@Trace_Cohen·t@nyvp.com